doi: 10.4306/pi.2014.11.3.342.
Epub 2014 Jul 21.
Serotonin Receptor 2C -759C/T Polymorphism and Weight Change or Treatment Response to Mirtazapine in Korean Depressive Patients
Affiliations
- PMID: 25110511
- PMCID: PMC4124197
- DOI: 10.4306/pi.2014.11.3.342
Item in Clipboard
Serotonin Receptor 2C -759C/T Polymorphism and Weight Change or Treatment Response to Mirtazapine in Korean Depressive Patients
Psychiatry Investig.
2014 Jul.
No abstract available
Similar articles
-
No Association between Serotonin Receptor 2C-759C/T Polymorphism and Weight Change or Treatment Response to Mirtazapine in Korean Depressive Patients.Psychiatry Investig. 2013 Jun;10(2):190-5. doi: 10.4306/pi.2013.10.2.190. Epub 2013 May 30. Psychiatry Investig. 2013. PMID: 23798968 Free PMC article.
-
Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals.Psychiatr Genet. 2004 Sep;14(3):139-42. doi: 10.1097/00041444-200409000-00003. Psychiatr Genet. 2004. PMID: 15318026
-
Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients.J Clin Pharm Ther. 2008 Feb;33(1):55-60. doi: 10.1111/j.1365-2710.2008.00872.x. J Clin Pharm Ther. 2008. PMID: 18211617
-
Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.J Affect Disord. 1998 Dec;51(3):267-85. doi: 10.1016/s0165-0327(98)00224-9. J Affect Disord. 1998. PMID: 10333982 Review.
-
Mirtazapine: clinical advantages in the treatment of depression.J Clin Psychopharmacol. 1997 Apr;17 Suppl 1:34S-39S. doi: 10.1097/00004714-199704001-00005. J Clin Psychopharmacol. 1997. PMID: 9090576 Review.
Cited by
-
Prediction of long-term treatment response to selective serotonin reuptake inhibitors (SSRIs) using scalp and source loudness dependence of auditory evoked potentials (LDAEP) analysis in patients with major depressive disorder.Int J Mol Sci. 2015 Mar 18;16(3):6251-65. doi: 10.3390/ijms16036251. Int J Mol Sci. 2015. PMID: 25794285 Free PMC article. Clinical Trial.
References
-
- Buckland PR, Hoogendoorn B, Guy CA, Smith SK, Coleman SL, O'Donovan MC. Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain. Am J Psychiatry. 2005;162:613–615. - PubMed
-
- Pae CU, Forbes A, Patkar AA. Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data. CNS Drugs. 2011;25:109–127. - PubMed
-
- Godlewska BR, Olajossy-Hilkesberger L, Ciwoniuk M, Olajossy M, Marmurowska-Michałowska H, Limon J, et al. Olanzapine-induced weight gain is associated with the -759C/T and -697G/C polymorphisms of the HTR2C gene. Pharmacogenomics J. 2009;9:234–241. - PubMed
-
- Vimaleswaran KS, Zhao JH, Wainwright NW, Surtees PG, Wareham NJ, Loos RJ. Association between serotonin 5-HT-2C receptor gene (HTR2C) polymorphisms and obesity- and mental health-related phenotypes in a large population-based cohort. Int J Obes (Lond) 2010;34:1028–1033. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
